Catalyst Pharmaceuticals

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$122,710
$98,509
$110,568
$102,688
Gross Profit
97,961
85,989
85,700
88,521
EBITDA
63,750
36,556
50,835
-28,620
EBIT
54,246
27,058
41,692
-37,254
Net Income
40,794
23,275
34,844
-30,764
Net Change In Cash
122,710
98,509
110,568
102,688
Free Cash Flow
64,125
31,726
19,555
-34,224
Cash
375,693
310,411
137,636
120,971
Basic Shares
124,655
123,403
113,755
106,568

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$398,204
$214,203
$140,833
$119,072
Gross Profit
313,672
179,810
118,949
102,033
EBITDA
119,955
103,077
52,577
42,188
EBIT
86,812
101,838
52,385
41,303
Net Income
71,410
83,079
39,482
74,983
Net Change In Cash
398,204
214,203
140,833
119,072
Cost of Revenue
126,950
41,208
Free Cash Flow
-54,924
116,018
59,351
45,023
Cash
137,636
298,395
171,445
130,237
Basic Shares
113,753
111,375
107,795
106,242

Earnings Calls

Quarter EPS
2024-06-30
$0.33
2024-03-31
$0.19
2023-12-31
$0.31
2023-09-30
-$0.29